Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study.
作者信息
Reville Patrick K, Kantarjian Hagop M, Ravandi Farhad, Jabbour Elias, DiNardo Courtney D, Daver Naval, Pemmaraju Naveen, Ohanian Maro, Alvarado Yesid, Xiao Lianchun, Alatrash Gheath, Loghavi Sanam, Rausch Caitlin R, Borthakur Gautam, Konopleva Marina, Cortes Jorge, Kadia Tapan M
机构信息
Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX, USA.
Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Boulevard, Houston, TX, USA.
出版信息
Blood Cancer J. 2021 Mar 17;11(3):60. doi: 10.1038/s41408-021-00453-z.
Abstract
摘要
Zotero 插件